Torrisi et al., 2018 - Google Patents
Gold nanoparticles by laser ablation for X-ray imaging and protontherapy improvementsTorrisi et al., 2018
View PDF- Document ID
- 17242831409158677590
- Author
- Torrisi L
- Restuccia N
- Paterniti I
- Publication year
- Publication venue
- Recent patents on Nanotechnology
External Links
Snippet
Background: Gold nanoparticles, 5-20 nm in diameter, were generated with a pulsed Nd: YAG laser at 1010 W/cm2 at solution concentrations ranging between 1-100 mg/ml. The incremental X-ray contrast imaging using gold nanoparticles was investigated and …
- 238000003384 imaging method 0 title abstract description 29
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1077—Beam delivery systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0009—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation
- A61K41/0019—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation by UV, IR, Rx or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240042233A1 (en) | Tumor imaging with x-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties | |
| Torrisi et al. | Gold nanoparticles by laser ablation for X-ray imaging and protontherapy improvements | |
| Guo et al. | Synthesis of BSA‐coated BiOI@ Bi2S3 semiconductor heterojunction nanoparticles and their applications for radio/photodynamic/photothermal synergistic therapy of tumor | |
| Tamarov et al. | Radio frequency radiation-induced hyperthermia using Si nanoparticle-based sensitizers for mild cancer therapy | |
| Zhao et al. | Simultaneous photodynamic and photothermal therapy using photosensitizer-functionalized Pd nanosheets by single continuous wave laser | |
| TWI741064B (en) | Pharmaceutical composition and kit for modifying a target structure which mediates or is associated with a biological activity | |
| Jeremic et al. | Radiosensitization by gold nanoparticles | |
| Guo et al. | Biocompatible chitosan-carbon nanocage hybrids for sustained drug release and highly efficient laser and microwave co-irradiation induced cancer therapy | |
| Torrisi et al. | Laser-produced Au nanoparticles as X-ray contrast agents for diagnostic imaging | |
| Torrisi | Gold nanoparticles enhancing protontherapy efficiency | |
| Detappe et al. | Key clinical beam parameters for nanoparticle-mediated radiation dose amplification | |
| Torrisi | Physical aspects of gold nanoparticles as cancer killer therapy: L Torrisi | |
| Torrisi | Radiotherapy improvements by using Au nanoparticles | |
| Torrisi et al. | Laser-generated Au nanoparticles for bio-medical applications | |
| Ortega et al. | Rodlike particles of polydopamine-CdTe quantum dots: an actuator as a photothermal agent and reactive oxygen species-generating nanoplatform for cancer therapy | |
| Liang et al. | A silica–gold–silica nanocomposite for Photothermal Therapy in the Near-Infrared Region | |
| Torrisi et al. | Study of gold nanoparticles for mammography diagnostic and radiotherapy improvements | |
| Torrisi | Evaluation of the radiotherapy and proton therapy improvements using gold nanoparticles | |
| US8884181B2 (en) | Method of generating low-energy secondary electrons for applications in biological sciences, radiochemistry, and chemistry of polymers and physics of radiotherapy | |
| Kakade et al. | Application of unlaminated EBT3 film dosimeter for quantification of dose enhancement using silver nanoparticle-embedded alginate film | |
| Torrisi et al. | Synthesis of bismuth nanoparticles for biomedical applications | |
| Zhang et al. | Enhancement of gastric cell radiation sensitivity by chitosan-modified gold nanoparticles | |
| Restuccia et al. | Nanoparticles generated by laser in liquids as contrast medium and radiotherapy intensifiers | |
| Kiran et al. | Emerging nanomaterials as radio-sensitizer in Radiotherapy | |
| Khumaeni et al. | Gold and silver nanoparticles as computed tomography (ct) contrast agents produced by a pulsed laser ablation technique: Study In-Vitro and In-Vivo |